Edwards play well outside home turf; S&N's recon unit rides high for Q4
This article was originally published in Clinica
Ophthalmic company Alcon rounded off fiscal 2007 with a strong fourth quarter performance. The Swiss incorporated company's surgical business enjoyed high growth in sales for its intraocular lenses (+24.3%), cataract and vitreoretinal products (+16.1%) and devices for refractive surgery (+75.4%) Refractive revenue was boosted by a $15.1m contribution from German refractive laser company WaveLight, of which Alcon became a majority shareholder in November 2007.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.